Skip to main content
. Author manuscript; available in PMC: 2011 May 15.
Published in final edited form as: Clin Cancer Res. 2010 May 11;16(10):2803–2810. doi: 10.1158/1078-0432.CCR-10-0026

Table 2.

Tumor Characteristics and PET Parameters by Subtype

Characteristics TN
n=25
HER2
n=6
Luminal
n=40
p-value
Global
difference by
subtype§
Odds ratio,
p-value
TN vs
Luminal
Tumor Grade
3 (versus 1 or 2)* 22 (88%) 4 (67%) 18 (45%) 8.7
95% CI (70%, 96%) (30%, 90%) (31%, 60%) 0.001 <0.001

Ki-67 proliferative index
High (versus low
or intermediate)
20 (95%) 3 (60%) 22 (63%) 0.01 11.4
0.009
95% CI (77%, 100%) (23%, 88%) (46%, 77%)

pCR
pCR (versus no or
partial response)
7 (28%) 4 (67%) 5 (13%) 0.014 2.7
0.188
95% CI (14%, 48%) (30%, 90%) (5%, 26%)

MRFDG, µmol/min/100 g
Mean 15.9 7.58 9.72 0.009 0.019
SD 10.4 5.31 7.8

BF, mL/min/g
Mean 0.354 0.315 0.352 0.731 0.773
SD 0.148 0.129 0.214

MRFDG: BF ratio
Mean 44.3 24.1 28.7 0.004 0.011
SD 23 14.6 14.6

Abbreviations: TN, triple negative; pCR, pathologic complete response; MRFDG, metabolic rate of fluorodeoxyglucose; BF, blood flow; CI, confidence interval

*

5 luminal tumors were grade 1, others were grade 2

Confidence intervals computed using Wilson (score) method

Missing values, n= 4 (TN), n=1 (Her2), n=5 (Luminal)

§

Fisher’s exact test for grade, Ki-67, pCR; likelihood ratio test for PET

Odds ratio and Fisher’s exact test p-value for grade, Ki-67, pCR; Tukey-Kramer test for PET (difference not given for log-transformed variables)